GGrantIndex
← Leaderboards

Mishaela R Rubin

Columbia University Health Sciences

$4,446,176
Attributed
$5,671,241
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,071,610 · 6
FDA$1,599,631 · 1

By mechanism

R01$4,003,417 · 3
K23$654,960 · 1
R21$453,472 · 1
RC4$400,002 · 1
R03$159,390 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Bone Turnover

Research focus

Bone TurnoverSkeletonPropertySkinBoneDevicesBone StrengthBone QualityAffectIndexingOrganMortalityElementsStructureHypoparathyroidismSkeletalTissuesBone DensityCohortOsteogenesisFracture RiskPreventProspectiveMorphology

Grant awards (23)

Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral Metabolism$399,999
R01 · FY2025 · FD · contact PI
Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral Metabolism$399,887
R01 · FY2024 · FD · contact PI
Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral Metabolism$399,858
R01 · FY2023 · FD · contact PI
Continuous calcium sensor patch for hypoparathyroid patients$283,500
R01 · FY2023 · DK
Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength$279,303
R01 · FY2023 · DK · contact PI
Skeletal Health in Youth with Type 1 Diabetes and Gender Diversity$100,000
R01 · FY2023 · DK · contact PI
Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral Metabolism$399,887
R01 · FY2022 · FD · contact PI
Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength$285,348
R01 · FY2022 · DK · contact PI
Continuous calcium sensor patch for hypoparathyroid patients$283,500
R01 · FY2022 · DK
Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength$290,934
R01 · FY2021 · DK · contact PI
Continuous calcium sensor patch for hypoparathyroid patients$283,500
R01 · FY2021 · DK
Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength$298,001
R01 · FY2020 · DK · contact PI
Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength$299,700
R01 · FY2019 · DK · contact PI
Skeletal Disease in Type 2 Diabetes: a Novel Therapeutic Approach for the Elderly$206,757
R21 · FY2019 · AG · contact PI
Skeletal Disease in Type 2 Diabetes: a Novel Therapeutic Approach for the Elderly$246,715
R21 · FY2018 · AG · contact PI
The Skeletal Effects of Reducing Inflammation in Type 2 Diabetes Mellitus$400,002
RC4 · FY2010 · DK · contact PI
Bone Quality in Hypoparathyroidism: Effects of PTH$130,992
K23 · FY2008 · DK · contact PI
Circulating Osteoblast Lineage Cells in Hypoparathyroidism$78,890
R03 · FY2008 · DK · contact PI
Bone Quality in Hypoparathyroidism: Effects of PTH$130,992
K23 · FY2007 · DK · contact PI
Circulating Osteoblast Lineage Cells in Hypoparathyroidism$80,500
R03 · FY2007 · DK · contact PI
Bone Quality in Hypoparathyroidism: Effects of PTH$130,992
K23 · FY2006 · DK · contact PI
Bone Quality in Hypoparathyroidism: Effects of PTH$130,992
K23 · FY2005 · DK
Bone Quality in Hypoparathyroidism: Effects of PTH$130,992
K23 · FY2004 · DK